Search Medical Condition
Please enter condition
Please choose location from dropdown

Monastir, Tunisia Clinical Trials

A listing of Monastir, Tunisia clinical trials actively recruiting patients volunteers.

RESULTS

Found (18) clinical trials

Global Non-interventional Heart Failure Disease Registry

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for ...

Phase N/A

10.74 miles

Learn More »

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP

Primary objective: To assess the efficacy of I10E in improving the disability of patients with CIDP. Secondary objective: To assess the safety of I10E in patients with CIDP.

Phase

10.74 miles

Learn More »

Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302

Primary objective: To assess the efficacy of I10E administered at a reduced maintenance dose in sustaining CIDP response after an initial 6-month treatment in PRISM study. (I10E-1302). Secondary objective: To assess the safety of I10E in this patient population.

Phase

10.74 miles

Learn More »

Study to Compare the Efficacy of Pristinamycin (Pyostacine ) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

The total study duration for each patient is 1 month with a treatment period of 7 to 9 days and a follow-up period of 21 to 23 days.

Phase

10.74 miles

Learn More »

The International Polycap Study 3 (TIPS-3)

Cardiovascular disease (CVD), cancers and osteoporosis collectively make up the largest disease burden globally. CVD is the major cause of death and disability and affects about half of the population over their lifetimes. Cancers are a leading cause of death and it accounts for 13.0% of all deaths. The commonest ...

Phase

3214.14 miles

Learn More »

Short Compared With Standard Duration of Antibiotic Treatment for AECOPD

This study is a randomized prospective double-blind, accomplished with sealed envelopes ,with two groups : Group A: Short treatment duration: 1 tablet Levofloxacin 500mg / day hang two days completed by 1 tablet Placebo Levofloxacin 500mg / day for 5 days. Group B: Standard treatment duration (control group): 1 tablet ...

Phase

Genetic Polymorphism Contributing to the Variability of Clopidogrel Response in Patients With Coronary Artery Disease

In an observational study with cross-sectional analysis and prospective data collection, the investigators recruit patients with: >20 years old An established coronary artery disease defined by an episode of STelevation myocardial infarction, nonSTelevation acute coronary syndrome or stable angina An exposure to clopidogrel therapy (75 mg per day for at ...

Phase N/A

0.97 miles

Learn More »

Smoking Cessation After Acute Coronary Syndrome

Background: Smoking is the main preventable cause worldwide of morbidity and premature death (1). It is a major and independent risk factor for coronary heart disease (CHD) (2). More than two-thirds of sudden cardiac death resulting from acute thrombus occurs in smokers (3). Compared to non-smokers the odds ratio (OR) ...

Phase N/A

0.97 miles

Learn More »

Treatment of Renal Colic in the Emergency Departement (ED).

Magnesium (MgSO4) is a N-Methyl-D-aspartate (NMDA) receptor antagonist and is thought to be involved in the modulation of pain. There has been little direct evidence that MgSO4 relieve neuropathic pain and prevents opioid-induced hyperalgesia in humans. Intramuscular Diclofenac seems to offer the most effective sustained analgesia for renal colic in ...

Phase

0.97 miles

Learn More »

Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD

This study is a randomized prospective double-blind, accomplished with sealed envelopes ,with three parallel groups : Group A: Short treatment: 1 tablet Levofloxacin 500mg / day hang two days completed by 1 tablet Placebo Levofloxacin 500mg / day for 5 days. Group B: Short Treatment control : 1 tablet Levofloxacin ...

Phase

0.97 miles

Learn More »